CLC Number:
- R654.2
| [1] Rigopoulos AG, Ali M, Abate E, et al.Review on Sud-den Death Risk Reduction after Septal Reduction Therapies in Hypertrophic Obstructive Cardiomyopathy[J].Heart Fail Rev, 2019, 24(3):359-366.DOI:10.1007/s10741-018-09767-w. [2] 蒙廷海,王水云,张燕搏,等.肥厚型梗阻性心肌病合并心肌桥的外科治疗策略和临床结果[J].中国心血管病研究,2019,21(1):35-39.DOI:10.3969/j.issn.1672-5301.2019.01.008. [3] Perry ME, Aris A, Michael AB, et al.2014 ESC Guidelines on Diagnosis and Management of Hypertrophic Cardiomyopathy:The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology(ESC)[J]. Eur Heart J, 2014,35(39):2733-2779.DOI:10.1093/eurheartj/ehu284. [4] 陈钊,刘健,唐亚捷,等. 全胸腔镜与正中开胸手术治疗肥厚型梗阻性心肌病的倾向性评分匹配分析[J]. 中国胸心血管外科临床杂志,2021,28(6):656-662. DOI:10.7507/1007-4848.202005027. [5] 曹娟,李方,周元,等.适时挤压胸管对胸腔镜肺部手术患者术后的影响[J].护理学报, 2017, 24(22):58-60.DOI:10.16460/j.jssn1008-9969.2017.22.058. |
| No related articles found! |
|